Scott Winslow
Overview
Explore the profile of Scott Winslow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigo M, Saiganesh A, Hayes A, Wilson A, Anstey J, Pickering J, et al.
Nat Commun
. 2022 Nov;
13(1):6557.
PMID: 36450721
Described antimicrobial resistance mechanisms enable bacteria to avoid the direct effects of antibiotics and can be monitored by in vitro susceptibility testing and genetic methods. Here we describe a mechanism...
2.
Hoffmann K, Milech N, Juraja S, Cunningham P, Stone S, Francis R, et al.
Sci Rep
. 2018 Aug;
8(1):12538.
PMID: 30135446
Cell penetrating peptides (CPPs) offer great potential to deliver therapeutic molecules to previously inaccessible intracellular targets. However, many CPPs are inefficient and often leave their attached cargo stranded in the...
3.
Stone S, Heinrich T, Juraja S, Satiaputra J, Hall C, Anastasas M, et al.
Biomolecules
. 2018 Jul;
8(3).
PMID: 29997382
The ability of cell penetrating peptides (CPPs) to deliver biologically relevant cargos into cells is becoming more important as targets in the intracellular space continue to be explored. We have...
4.
Milech N, Longville B, Cunningham P, Scobie M, Bogdawa H, Winslow S, et al.
Sci Rep
. 2015 Dec;
5:18329.
PMID: 26671759
Efficient cargo uptake is essential for cell-penetrating peptide (CPP) therapeutics, which deliver widely diverse cargoes by exploiting natural cell processes to penetrate the cell's membranes. Yet most current CPP activity...
5.
Barnard D, Day C, Bailey K, Heiner M, Montgomery R, Lauridsen L, et al.
Antiviral Res
. 2006 Apr;
71(1):53-63.
PMID: 16621037
Because of the conflicting data concerning the SARS-CoV inhibitory efficacy of ribavirin, an inosine monophosphate (IMP) dehydrogenase inhibitor, studies were done to evaluate the efficacy of ribavirin and other IMP...